iSpecimen Inc. (ISPC)
NASDAQ: ISPC · IEX Real-Time Price · USD
0.295
-0.008 (-2.74%)
At close: Jul 2, 2024, 4:00 PM
0.299
+0.005 (1.56%)
After-hours: Jul 2, 2024, 7:55 PM EDT
iSpecimen Market Cap
iSpecimen has a market cap or net worth of $3.85 million as of July 2, 2024. Its market cap has decreased by -69.41% in one year.
Market Cap
3.85M
Enterprise Value
1.45M
1-Year Change
-69.41%
Ranking
Category
Stock Price
$0.29
Market Cap Chart
Since the IPO on June 17, 2021, iSpecimen's market cap has decreased from $50.15M to $3.85M, a decrease of -92.31%. That is a compound annual growth rate of -56.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 3.00M | -33.33% |
| Dec 29, 2023 | 4.50M | -62.50% |
| Dec 30, 2022 | 12.00M | -82.40% |
| Dec 31, 2021 | 68.20M | 36.01% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Predictive Oncology | 4.27M |
| Palisade Bio | 4.21M |
| Portage Biotech | 4.20M |
| Bio-Path Holdings | 4.16M |
| Theriva Biologics | 4.08M |
| Sonoma Pharmaceuticals | 4.03M |
| Protagenic Therapeutics | 4.03M |
| Trevena | 4.00M |